BenevolentAI
BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
Business Model:
Revenue: $0
Employees: 201-500
Detailed BenevolentAI Information
Geographic Data
Address: 4-8 Maple Street
City: London
State: england
Zip: W1T 5HD
Country: GB
Financial Info
Stage:
private equity
Raised Last:
$90M
Raised Total:$292M
Social
Metrics
1,431,614Website Global Rank
18,768Website Monthly Traffic
Twitter Followers
Description
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. BenevolentAI has a consistently proven track record of scientifically validated discoveries. The Benevolent Platform™ powers a growing in-house pipeline of over 20 disease programmes, spanning from target discovery to clinical studies, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Contact Phone:
Contact Email:
BenevolentAI went public on 4/25/2022 on the Other
Listed Exchange:
Other
IPO Date:
4/25/2022
IPO Valuation:
$2B
Ticker Symbol:
BAI
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2022 | IPO SPAC | $242.9M |
|
4/2018 | Funding Round | $0 |
Goldman Sachs Woodford Investment Management Woodford Investment Management Goldman Sachs Woodford Investment Management Woodford Investment Management |
8/2015 | Venture Round | $0 |
Lansdowne Partners Lundbeck Upsher Smith Laboratories Woodford Investment Management Lansdowne Partners Lundbeck Upsher Smith Laboratories Woodford Investment Management |
9/2019 | Private Equity Round | 1 | $90M |
Temasek Holdings Temasek Holdings Temasek Holdings Temasek Holdings |
4/2018 | Equity | 2 | $115M |
Woodford Investment Management Goldman Sachs Woodford Investment Management Woodford Investment Management |
8/2015 | Equity | 4 | $87M |
Woodford Investment Management Lansdowne Partners Lansdowne Partners Lundbeck Upsher Smith Laboratories Woodford Investment Management |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
